Represent

Donate

Lobbying Relationship

Client

Allergan, plc (formerly known as Actavis)

More records

Lobbying firm

Van Heuvelen Strategies, LLC

More records

  • Issues related to implementation of the FDA user fee reauthorization bill Issues related to the Inter Partes Review (IPR) process S. 344, H.R. 990, Hatch-Waxman Integrity Act of 2019 S. 340, H.R. 965, CREATES Act of 2019 Issues related to drug compounding and counterfeit drugs S. 440, PACED Act

Duration: to

General Issues: Health Issues, Budget/Appropriations, Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code, Copyright/Patent/Trademark

Spending: about $1,200,000 (But it's complicated. Here's why.)

Agencies lobbied since 2013: U.S. Senate, House of Representatives, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA)

Bills mentioned

S.297: Increasing Competition in Pharmaceuticals Act

Sponsor: Susan Collins (R-Maine)

H.R.749: Lower Drug Costs through Competition Act

Sponsor: Kurt Schrader (D-Ore.)

H.R.5325: Continuing Appropriations and Military Construction, Veterans Affairs,...

Sponsor: Tom Graves (R-Ga.)

H.R.34: 21st Century Cures Act

Sponsor: Suzanne Bonamici (D-Ore.)

S.2615: Increasing Competition in Pharmaceuticals Act

Sponsor: Susan Collins (R-Maine)

H.R.4784: Lower Drug Costs through Competition Act

Sponsor: Kurt Schrader (D-Ore.)

H.R.6: 21st Century Cures Act

Sponsor: Fred Upton (R-Mich.)

H.R.9: Innovation Act

Sponsor: Robert W. Goodlatte (R-Va.)

H.R.2045: Targeting Rogue and Opaque Letters Act of 2015

Sponsor: Michael C. Burgess (R-Texas)

S.632: STRONG Patents Act of 2015

Sponsor: Christopher A. Coons (D-Del.)

S.1137: PATENT Act

Sponsor: Charles E. Grassley (R-Iowa)

H.R.2: Medicare Access and CHIP Reauthorization Act of 2015

Sponsor: Michael C. Burgess (R-Texas)

H.R.3204: Drug Quality and Security Act

Sponsor: Fred Upton (R-Mich.)

H.R.3309: Innovation Act

Sponsor: Robert W. Goodlatte (R-Va.)

S.1013: Patent Abuse Reduction Act of 2013

Sponsor: John Cornyn (R-Texas)

S.1612: Patent Litigation Integrity Act of 2013

Sponsor: Orrin G. Hatch (R-Utah)

S.1720: Patent Transparency and Improvements Act of 2013

Sponsor: Patrick J. Leahy (D-Vt.)

S.2049: Transparency in Assertion of Patents Act

Sponsor: Claire McCaskill (D-Mo.)

S.2768: Emergency Fuel Reduction Act of 2014

Sponsor: Dean Heller (R-Nev.)

S.2540: Patriot Employer Tax Credit Act

Sponsor: Richard J. Durbin (D-Ill.)

H.R.325: No Budget, No Pay Act of 2013

Sponsor: Dave Camp (R-Mich.)

S.CON.RES.8: An original concurrent resolution setting forth the congressional budget...

Sponsor: Patty Murray (D-Wash.)

S.214: Preserve Access to Affordable Generics Act

Sponsor: Amy Klobuchar (D-Minn.)

H.R.1919: Safeguarding America's Pharmaceuticals Act of 2013

Sponsor: Robert E. Latta (R-Ohio)

S.959: Pharmaceutical Quality, Security, and Accountability Act

Sponsor: Tom Harkin (D-Iowa)

S.2295: National Commission on the Future of the Army Act of 2014

Sponsor: Patrick J. Leahy (D-Vt.)

S.344: Hatch-Waxman Integrity Act of 2019

Sponsor: Thom Tillis (R-N.C.)

H.R.990: Hatch-Waxman Integrity Act of 2019

Sponsor: Bill Flores (R-Texas)

S.340: CREATES Act of 2019

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.965: CREATES Act of 2019

Sponsor: David Cicilline (D-R.I.)

S.440: PACED Act

Sponsor: Tom Cotton (R-Ark.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Robert Van Heuvelen Chief of Staff to Senator Kent Conrad
Diane Major Health Policy Analyst, Sen. Rep. Policy Cmte. Health Analyst for Senator Craig Thomas Professional Staff, Cmte. on Govt. Operations Legislative Assistant, Congressman Craig Thomas Health Policy Analyst, Sen. Repub. Policy Com. Professional Staff, Com. on Govt Operations
Stephen Ward Chief of Staff to Senator Jeff Bingaman
Robert Van Huevelen Chief of Staff to Senator Kent Conrad

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Amendment
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Amendment
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page